ArticleCancers2022

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.

Jean-Baptiste Assié et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.